Novel compound for treating sensitive, isoniazid resistant strains and multi drug resistant mycobacterium tuberculosis

摘要

ABSTRACT A method for separating compound 4-(5,7-dihydroxy-3-methoxy-4-oxo-4H-chromen-2-yl) phenylacetate from Alpinia officinarum and composition thereof for treating Mycobacterium tuberculosis infection inclusive of avirulent H37Ra, standard virulent H37Rv strains and isoniazid resistant and multidrug resistant strains.